Key result
DCB angioplasty simplifies complex PCI by reducing permanent stents and facilitating positive vessel remodeling.
Why the study?
Drug-coated balloon therapy is increasingly used to simplify treatment of complex coronary artery disease, but its role compared to drug-eluting stents in complex PCI requires further elucidation.
Answers are grounded in this paper and cite their sources.
DCB may simplify complex PCI in select lesions; leaves open whether stent-sparing approaches improve outcomes over standard stenting.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tuomas T. Rissanen (2026) conducted an editorial in Complex coronary artery disease. Drug-coated balloon (DCB) vs. Drug-eluting stent (DES) was evaluated. Drug-coated balloon (DCB) angioplasty represents an evolving strategy capable of simplifying complex percutaneous coronary interventions by reducing the need for permanent metal stents and facilitating positive vessel remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: